Saturday - July 12, 2025
European Hematology Association, European Myeloma Network Include Pepaxti in New Clinical Practice Guidelines for Relapsed/Refractory Multiple Myeloma
July 09, 2025
NORTH HOLLYWOOD, California, July 9 -- The International Myeloma Foundation issued the following news:

* * *

European Hematology Association (EHA) and the European Myeloma Network (EMN) Include Pepaxti in New Clinical Practice Guidelines for Relapsed/Refractory Multiple Myeloma (RRMM)

According to a press release from Oncopeptides, "its drug Pepaxti has been included in new clinical practice guidelines from EHA-EMN* for patients with relapsed, refracto . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products